Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.569
Delayed Data
As of 10:47am ET
 +0.009 / +1.61%
Today’s Change
0.49
Today|||52-Week Range
3.72
-18.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues735.0K247.0K512.0K296.0K
 
 
 
 
 
Depreciation And Amortization69.0K59.0K52.0K50.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses6.3M6.0M5.8M3.9M
 
 
 
 
 
Research And Development4.9M4.4M4.3M2.5M
 
 
 
 
 
Total Operating Expenses6.4M6.0M5.8M3.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-5.8M-5.3M-3.6M
 
 
 
 
 
Extraordinary Charge-4.0K-227.0K-20.0K-4.0K
 
 
 
 
 
Other Expenses10.0K101.0K-358.0K-133.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-5.9M-5.7M-3.8M
 
 
 
 
 
Income Taxes-750.0K-1.1M-763.0K-405.0K
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Discontinued Operations4.0K0.000.000.00
 
 
Net Income-4.9M-4.8M-4.9M-3.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.7M23.0M26.1M34.4M
 
 
 
 
 
Shares To Calculate EPS Diluted22.7M23.0M26.1M34.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.21-$0.19-$0.10
 
 
 
 
 
EPS Diluted-$0.22-$0.21-$0.19-$0.10